Rapid testing solutions to get back to business

Implementing simple safety measures can help reduce risks of spreading COVID-19 as businesses and employers resume operations, client meetings, corporate travel, and more. COVID-19 safety measures can include physical distancing, masking, handwashing, and testing. Developing a testing plan can allow you the flexibility to scale up or down as guidelines or trends in COVID-19 infections evolve.

Some benefits of testing include:

  • Reduce risk of spreading COVID-19 in the workplace
  • Enhance employee confidence in safety protocols
  • Minimize cancellation of business or client meetings due to COVID-19
  • Lessen productivity losses from staff shortages, outbreaks, or shutdowns
  • Limit disruptions to business operations
  • Compliance with evolving local and state regulated guidelines and protocols

Refer to CDC Guidelines for the most current local guidance.

image_9f40.img.full.high.png

Learn more about rapid PCR testing with the Thermo Fisher Scientific Accula system


Are you looking to schedule an individual COVID-19 test? Find a Rapid PCR test provider


A path forward to bring people back together safely

As a leading single source-supplier of COVID-19 testing worldwide, we can partner with your organization to curate and implement a solution that provides simplicity and convenience at every step. Our team can offer support for in-house testing or connect you with a full-service testing provider. Unlike some providers, there’s no need to commit to long-term contracts, giving you the flexibility to test on your terms.

3 simple steps to help make your meetings safer


Just tell us about your company or event, and we will help you choose a testing solution that fits your needs and budget

We aim to simplify and streamline your testing and reporting so your workforce can remain healthy and productive

We optimize your testing program to meet your evolving needs, helping to ensure that they are scalable, cost-efficient and most importantly, effective


Frequently asked questions

If your organization has a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver, your staff can bring our rapid testing solutions in-house. Businesses looking for turn-key solutions can work with one of our full-service providers that can manage all logistics from registration, to testing, and reporting of results.

If you work with a full-service testing provider, the testing administrator can process samples. They will provide test results and initiate reporting through dashboards and/or notification alerts.

Testing costs are influenced by a variety of factors including the volume of tests, frequency of testing, and type of testing that is selected. Organizations can consider over-the-counter (OTC) testing solutions but may require additional support for manual reporting and management by staff. Request a free consultation from Thermo Fisher Scientific to learn about your options, which include added benefits of reporting, dashboards, and notifications for administrators and individuals. 

Request a free consultation today

Testing can be administered for groups of all sizes. Depending on the volume and frequency of testing your organization needs, we can recommend different approaches to reduce waiting time and limit disruptions to operations. If guidelines or trends evolve, testing can scale up or down to meet your needs with no long-term contracts.

RT-PCR (Reverse Transcription Polymerase Chain Reaction) is a method of detecting nucleic acid (in this case RNA, the genetic material of the SARS-CoV-2 virus) in order to determine the presence of virus in a sample. The Accula SARS-CoV-2 Test sensitivity and accuracy is comparable to lab based PCR1.

The ~30-minute RT-PCR rapid test is the Accula SARS-CoV-2 Test from Thermo Fisher Scientific, a leading provider of scientific equipment, assays, and reagents.


Speak to a specialist today

*
*
*
*
*
*
*
*
*
*
*
 Workspace
 Event
 Other
*
 Please confirm you would like to receive marketing and promotional email messages about products and services from Thermo Fisher Scientific and its brands in accordance with our privacy statement.
 
 

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Thermo Fisher ScientificPrivacy Policy.


NOTE: Testing for the Accula SARS-CoV-2 Test is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate, or waived complexity tests. The Accula SARS-CoV-2 Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

 This test has not been FDA cleared or approved but has been authorized for emergency use by the FDA for use by laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C. §263a, that meet requirements to perform high, moderate, or waived complexity tests. The test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

For Emergency Use Authorization (EUA) Only. For prescription use only. For in vitro diagnostic use.

Style Sheet for Global Design System
Style Sheet for Komodo Tabs